{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:29:29Z","timestamp":1791646169481,"version":"4.3.4"},"reference-count":64,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.5551\/jat.65939","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:07:49Z","timestamp":1762898869000},"page":"384-401","source":"Crossref","is-referenced-by-count":4,"title":["An Apparent Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with High Levels of Estimated Small Dense LDL Cholesterol in a Japanese Population"],"prefix":"10.5551","volume":"33","author":[{"given":"Rie","family":"Matsumori","sequence":"first","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marenao","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"},{"name":"Division of Cellular Physiology and Signal Transduction, Department of Physiology, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Surgery, Department of Surgery, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Nakata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Kawaharata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Aida","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Nishizawa","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemichi","family":"Kouzu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Yama","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Radiology, Department of Radiology, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagisa","family":"Hanawa","sequence":"additional","affiliation":[{"name":"Department of Health Checkup and Promotion, Keijinkai Maruyama Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Israelsen M, Francque S, Tsochatzis EA, Krag A: Steatotic liver disease. Lancet, 2024; 404: 1761-1778","DOI":"10.1016\/S0140-6736(24)01811-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ratziu V, Rinella M, Beuers U, Loomba R, Anstee QM, Harrison S, Francque S, Sanyal A, Newsome PN, Younossi Z: The times they are a-changin\u2019 (for NAFLD as well). J Hepatol, 2020; 73: 1307-1309","DOI":"10.1016\/j.jhep.2020.08.028"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gomez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, group NNc: A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol, 2023; 79: 1542-1556","DOI":"10.1016\/j.jhep.2023.06.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L: The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology, 2023; 77: 1335-1347","DOI":"10.1097\/HEP.0000000000000004"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology, 1999; 116: 1413-1419","DOI":"10.1016\/S0016-5085(99)70506-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Adams LA, Anstee QM, Tilg H, Targher G: Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut, 2017; 66: 1138-1153","DOI":"10.1136\/gutjnl-2017-313884"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A, Haflidadottir S, Bendtsen F: Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology, 2015; 149: 389-397 e310","DOI":"10.1053\/j.gastro.2015.04.043"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Castillo-Nunez Y, Almeda-Valdes P, Gonzalez-Galvez G, Arechavaleta-Granell MDR: Metabolic dysfunction-associated steatotic liver disease and atherosclerosis. Curr Diab Rep, 2024; 24: 158-166","DOI":"10.1007\/s11892-024-01542-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Mori K, Akiyama Y, Tanaka M, Sato T, Endo K, Hosaka I, Hanawa N, Sakamoto N, Furuhashi M: Deciphering metabolic dysfunction-associated steatotic liver disease: insights from predictive modeling and clustering analysis. J Gastroenterol Hepatol, 2024; 39: 1382-1393","DOI":"10.1111\/jgh.16552"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Packard CJ: Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans, 2003; 31: 1066-1069","DOI":"10.1042\/bst0311066"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Hirano T: Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes. J Diabetes Investig, 2025; 16: 370-383","DOI":"10.1111\/jdi.14398"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Krauss RM: Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care, 2004; 27: 1496-1504","DOI":"10.2337\/diacare.27.6.1496"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Williams PT, Superko HR, Haskell WL, Alderman EL, Blanche PJ, Holl LG, Krauss RM: Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol, 2003; 23: 314-321","DOI":"10.1161\/01.ATV.0000053385.64132.2D"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ikezaki H, Furusyo N, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJ: Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression. J Atheroscler Thromb, 2020; 27: 1108-1122","DOI":"10.5551\/jat.54130"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Takiwaki M, Tomoda F, Koike T, Taki T, Inoue H, Kigawa M, Kitajima I, Uji Y: Increased levels of small dense low-density lipoprotein cholesterol associated with hemorheological abnormalities in untreated, early-stage essential hypertensives. Hypertens Res, 2014; 37: 1008-1013","DOI":"10.1038\/hr.2014.111"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ikezaki H, Lim E, Cupples LA, Liu CT, Asztalos BF, Schaefer EJ: Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study. J Am Heart Assoc, 2021; 10: e019140","DOI":"10.1161\/JAHA.120.019140"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, Sethi A, Fleming JK, Otvos JD, Meeusen JW, Delaney SR, Jaffe AS, Shamburek R, Amar M, Remaley AT: A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and\/or Hypertriglyceridemia. JAMA Cardiol, 2020; 5: 540-548","DOI":"10.1001\/jamacardio.2020.0013"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sampson M, Wolska A, Warnick R, Lucero D, Remaley AT: A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test. Clin Chem, 2021; 67: 987-997","DOI":"10.1093\/clinchem\/hvab048"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hirano T, Ito Y: Accuracy of Small Dense Low-density Lipoprotein-cholesterol Concentration Estimated via Sampson\u2019s Equation in Healthy Subjects and Patients with Diabetes. J Atheroscler Thromb, 2023; 30: 979-989","DOI":"10.5551\/jat.63865"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Endo K, Kobayashi R, Tanaka M, Tanaka M, Akiyama Y, Sato T, Hosaka I, Nakata K, Koyama M, Ohnishi H, Takahashi S, Furuhashi M: Validation of Estimated Small Dense Low-Density Lipoprotein Cholesterol Concentration in a Japanese General Population. J Atheroscler Thromb, 2024; 31: 931-952","DOI":"10.5551\/jat.64578"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ichikawa T, Okada H, Hamaguchi M, Kurogi K, Murata H, Ito M, Fukui M: Estimated small dense low-density lipoprotein-cholesterol and incident type 2 diabetes in Japanese people: Population-based Panasonic cohort study 13. Diabetes Res Clin Pract, 2023; 199: 110665","DOI":"10.1016\/j.diabres.2023.110665"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Tanaka M, Sato T, Endo K, Inyaku M, Mori K, Hosaka I, Mikami T, Akiyama Y, Ohnishi H, Hanawa N, Furuhashi M: An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort. Hypertens Res, 2023; 46: 2635-2645","DOI":"10.1038\/s41440-023-01392-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Aida H, Tanaka M, Sato T, Kawaharata W, Matsumori R, Hosaka I, Akiyama Y, Nakata K, Kouzu H, Hanawa N, Furuhashi M: Elevated level of estimated small dense LDL cholesterol is independently associated with the development of hypertension regardless of LDL cholesterol level. Hypertens Res, 2025;","DOI":"10.1038\/s41440-025-02374-x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Inyaku M, Tanaka M, Sato T, Endo K, Mori K, Hosaka I, Mikami T, Umetsu A, Ohnishi H, Akiyama Y, Hanawa N, Furuhashi M: Calculated Small Dense Low-Density Lipoprotein Cholesterol Level is A Predominant Predictor for New Onset of Ischemic Heart Disease. J Atheroscler Thromb, 2024; 31: 232-248","DOI":"10.5551\/jat.64369"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Endo K, Tanaka M, Sato T, Inyaku M, Nakata K, Kawaharata W, Aida H, Hosaka I, Akiyama Y, Hanawa N, Furuhashi M: High Level of Estimated Small Dense Low-Density Lipoprotein Cholesterol as an Independent Risk Factor for the Development of Ischemic Heart Disease Regardless of Low-Density Lipoprotein Cholesterol Level - A 10-Year Cohort Study. Circ J, 2025; 89: 1182-1189","DOI":"10.1253\/circj.CJ-24-0770"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kanda D, Tokushige A, Ohishi M: Association between Estimated Small Dense Low-Density Lipoprotein Cholesterol and Occurrence of New Lesions after Percutaneous Coronary Intervention in Japanese Patients with Stable Angina and Receiving Statin Therapy. Rev Cardiovasc Med, 2024; 25: 218","DOI":"10.31083\/j.rcm2506218"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Sato T, Tanaka M, Furuhashi M: Can small dense LDL cholesterol be estimated from the lipid profile? Curr Opin Lipidol, 2025; 36: 198-202","DOI":"10.1097\/MOL.0000000000000989"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H, Hirawa N: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res, 2019; 42: 1235-1481","DOI":"10.1038\/s41440-019-0284-9"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) American Diabetes Association: 2. Classification and Diagnosis of Diabetes. Diabetes Care, 2017; 40: S11-S24","DOI":"10.2337\/dc17-S005"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. J Atheroscler Thromb, 2024; 31: 641-853","DOI":"10.5551\/jat.GL2022"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Examination Committee of Criteria for \u2018Obesity Disease\u2019 in J, Japan Society for the Study of O: New criteria for \u2018obesity disease\u2019 in Japan. Circ J, 2002; 66: 987-992","DOI":"10.1253\/circj.66.987"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, Kato T, Takeda N, Okuda J, Ida K, Kawahito Y, Yoshikawa T, Okanoue T: The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol, 2007; 102: 2708-2715","DOI":"10.1111\/j.1572-0241.2007.01526.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Staufer K, Stauber RE: Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both? Biomedicines, 2023; 11:","DOI":"10.3390\/biomedicines11082108"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics, 1988; 44: 837-845","DOI":"10.2307\/2531595"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Pencina MJ, D\u2019Agostino RB, Pencina KM, Janssens AC, Greenland P: Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol, 2012; 176: 473-481","DOI":"10.1093\/aje\/kws207"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Pencina MJ, D\u2019Agostino RB, Sr., Steyerberg EW: Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med, 2011; 30: 11-21","DOI":"10.1002\/sim.4085"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Kanda Y: Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant, 2013; 48: 452-458","DOI":"10.1038\/bmt.2012.244"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Abe S, Haruyama Y, Kobashi G, Toyoda S, Inoue T, Tomiyama H, Ishizu T, Kohro T, Higashi Y, Takase B, Suzuki T, Ueda S, Yamazaki T, Furumoto T, Kario K, Koba S, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Yamashina A: Effect of Novel Stratified Lipid Risk by \u201cLDL-Window\u201d and Flow-Mediated Dilation on the Prognosis of Coronary Artery Disease Using the FMD-J Study A Data. Circ J, 2022; 86: 1444-1454","DOI":"10.1253\/circj.CJ-21-1068"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Hosoyamada K, Uto H, Imamura Y, Hiramine Y, Toyokura E, Hidaka Y, Kuwahara T, Kusano K, Saito K, Oketani M, Ido A, Tsubouchi H: Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol. Diabetol Metab Syndr, 2012; 4: 34","DOI":"10.1186\/1758-5996-4-34"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Hirano T, Satoh N, Ito Y: Specific Increase in Small Dense Low-Density Lipoprotein-Cholesterol Levels beyond Triglycerides in Patients with Diabetes: Implications for Cardiovascular Risk of MAFLD. J Atheroscler Thromb, 2024; 31: 36-47","DOI":"10.5551\/jat.64271"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Jiang S, Zhang F, Yang H, Han X, Mao J, Zheng G, Fan Y: Estimated sdLDL-C as a biomarker of hepatic steatosis severity in MASLD: a retrospective study. BMC Gastroenterol, 2025; 25: 168","DOI":"10.1186\/s12876-025-03759-5"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Huang H, Xie J, Hou L, Miao M, Xu L, Xu C: Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations. J Diabetes Investig, 2024; 15: 491-499","DOI":"10.1111\/jdi.14133"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Tokuno A, Hirano T, Hayashi T, Mori Y, Yamamoto T, Nagashima M, Shiraishi Y, Ito Y, Adachi M: The effects of statin and fibrate on lowering small dense LDL- cholesterol in hyperlipidemic patients with type 2 diabetes. J Atheroscler Thromb, 2007; 14: 128-132","DOI":"10.5551\/jat.14.128"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Suzuki T, Sato T, Tanaka M, Nakata K, Endo K, Aida H, Kawaharata W, Hosaka I, Umetsu A, Ogawa T, Akiyama Y, Furuhashi M: Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne), 2025; 16: 1496671","DOI":"10.3389\/fendo.2025.1496671"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Arai H, Kokubo Y, Watanabe M, Sawamura T, Ito Y, Minagawa A, Okamura T, Miyamato Y: Small dense low-density lipoproteins cholesterol can predict incident cardiovascular disease in an urban Japanese cohort: the Suita study. J Atheroscler Thromb, 2013; 20: 195-203","DOI":"10.5551\/jat.14936"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Higashioka M, Sakata S, Honda T, Hata J, Yoshida D, Hirakawa Y, Shibata M, Goto K, Kitazono T, Osawa H, Ninomiya T: Small Dense Low-Density Lipoprotein Cholesterol and the Risk of Coronary Heart Disease in a Japanese Community. J Atheroscler Thromb, 2020; 27: 669-682","DOI":"10.5551\/jat.51961"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Ogawa T, Sato T, Tanaka M, Akiyama Y, Nakata K, Kouzu H, Mori K, Aida H, Kawaharata W, Hosaka I, Suzuki T, Hanawa N, Furuhashi M: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Is an Independent Risk Factor for the Development of Ischemic Heart Disease - A 10-Year Cohort Study. Circ Rep, 2025; 7: 350-358","DOI":"10.1253\/circrep.CR-25-0019"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Mori K, Tanaka M, Sato T, Akiyama Y, Endo K, Ogawa T, Suzuki T, Aida H, Kawaharata W, Nakata K, Hosaka I, Umetsu A, Hanawa N, Furuhashi M: Metabolic dysfunction-associated steatotic liver disease (SLD) and alcohol-associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10-year follow-up period. Hepatol Res, 2024;","DOI":"10.1111\/hepr.14097"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Hagstrom H, Vessby J, Ekstedt M, Shang Y: 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J Hepatol, 2024; 80: e76-e77","DOI":"10.1016\/j.jhep.2023.08.026"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Mantovani A, Csermely A, Petracca G, Beatrice G, Corey KE, Simon TG, Byrne CD, Targher G: Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol, 2021; 6: 903-913","DOI":"10.1016\/S2468-1253(21)00308-3"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Chan KE, Ong EYH, Chung CH, Ong CEY, Koh B, Tan DJH, Lim WH, Yong JN, Xiao J, Wong ZY, Syn N, Kaewdech A, Teng M, Wang JW, Chew N, Young DY, Know A, Siddiqui MS, Huang DQ, Tamaki N, Wong VW, Mantzoros CS, Sanyal A, Noureddin M, Ng CH, Muthiah M: Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies. Clin Gastroenterol Hepatol, 2024; 22: 488-498 e414","DOI":"10.1016\/j.cgh.2023.09.018"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Stahl EP, Dhindsa DS, Lee SK, Sandesara PB, Chalasani NP, Sperling LS: Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review. J Am Coll Cardiol, 2019; 73: 948-963","DOI":"10.1016\/j.jacc.2018.11.050"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Li M, Wang H, Zhang XJ, Cai J, Li H: NAFLD: An Emerging Causal Factor for Cardiovascular Disease. Physiology (Bethesda), 2023; 38: 0","DOI":"10.1152\/physiol.00013.2023"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Baraona E, Lieber CS: Alcohol and lipids. Recent Dev Alcohol, 1998; 14: 97-134","DOI":"10.1007\/0-306-47148-5_5"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Sierksma A, Vermunt SH, Lankhuizen IM, van der Gaag MS, Scheek LM, Grobbee DE, van Tol A, Hendriks HF: Effect of moderate alcohol consumption on parameters of reverse cholesterol transport in postmenopausal women. Alcohol Clin Exp Res, 2004; 28: 662-666","DOI":"10.1097\/01.ALC.0000122763.30770.F5"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Kralova Lesna I, Suchanek P, Stavek P, Poledne R: May alcohol-induced increase of HDL be considered as atheroprotective? Physiol Res, 2010; 59: 407-413","DOI":"10.33549\/physiolres.931769"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) van der Gaag MS, van Tol A, Vermunt SH, Scheek LM, Schaafsma G, Hendriks HF: Alcohol consumption stimulates early steps in reverse cholesterol transport. J Lipid Res, 2001; 42: 2077-2083","DOI":"10.1016\/S0022-2275(20)31537-6"},{"key":"59","unstructured":"59) Senault C, Betoulle D, Luc G, Hauw P, Rigaud D, Fumeron F: Beneficial effects of a moderate consumption of red wine on cellular cholesterol efflux in young men. Nutr Metab Cardiovasc Dis, 2000; 10: 63-69"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Hartung GH, Lawrence SJ, Reeves RS, Foreyt JP: Effect of alcohol and exercise on postprandial lipemia and triglyceride clearance in men. Atherosclerosis, 1993; 100: 33-40","DOI":"10.1016\/0021-9150(93)90065-3"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Jeon S, Carr R: Alcohol effects on hepatic lipid metabolism. J Lipid Res, 2020; 61: 470-479","DOI":"10.1194\/jlr.R119000547"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Marigorta UM, Millet O, Lu SC, Mato JM: Dysfunctional VLDL metabolism in MASLD. NPJ Metab Health Dis, 2024; 2: 16","DOI":"10.1038\/s44324-024-00018-1"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Burks KH, Stitziel NO, Davidson NO: Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic Disease. Cell Mol Gastroenterol Hepatol, 2025; 19: 101409","DOI":"10.1016\/j.jcmgh.2024.101409"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Lucero D, Zago V, Lopez GI, Graffigna M, Lopez GH, Fainboim H, Miksztowicz V, Gomez Rosso L, Belli S, Levalle O, Berg G, Brites F, Wikinski R, Schreier L: Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome? Clin Chim Acta, 2011; 412: 587-592","DOI":"10.1016\/j.cca.2010.12.012"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/4\/33_65939\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:25:29Z","timestamp":1775276729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/4\/33_65939\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65939","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"65939"}}